Roundup: Genomics Englappoints new chief scientific officer, NHS Charities award £1.1M to CW+ more briefs


Humber Teaching NHS FT has enabled its EPR move to the cloud through Dedalus’ Healthcare Platform.

With the trust’s strategy being to move core applications to the cloud, the platform has provided a secure flexible cloud service that the trust are leveraging, with the ability to host patient identifiable data. 

The trust is now also benefiting from a set of common shared platform services such as remote access, deployment automation, network security monitoring.  

The platform is hosted on Amazon Public Cloud leverages Amazon Web Services (AWS) Cloud Computing Services AWS Managed Services (AMS). This provides the trust with a secure service leveraging multiple “availability zones”, within AWS Public Cloud. 


According to GlobalData’s deals database, led by $600 million venture financing of CMR Surgical, total medical devices industry cross border venture financing deals worth $1.4bn were announced in Europe in Q2 2021.

The data showed that value marked an increase of 856.8% over the previous quarter a rise of 574.8% when compared with the last four-quarter average of $210.43 million.

Furthermore, Europe held a 30.21% share of the global medical devices industry cross border venture financing deal value that totalled $4.7 billion in Q2 2021. With a 22.98% share deals worth $1.08 billion, the UK was the top country in Europe’s cross border venture financing deal value across medical devices industry.

In terms of deal activity, Europe recorded 30 cross border deals during Q2 2021, marking an increase of 87.50% over the previous quarter a rise of 66.67% over the last four-quarter average. The UK recorded 11 deals during the month.


Genomics Englhas announced the appointment of Professor Matt Brown as the organisation’s new chief scientific officer.

Professor Brown is a clinician-scientist is currently Professor of Medicine at Kings College London, as well as director of the NIHR Biomedical Research Centre at Guy’s St Thomas’.

He has a background in genomics has previously been director of genomics Professor at the QueenslUniversity of Technology.

Genomics England’s CEO Chris Wigley, said: “We’re delighted Professor Matt Brown has accepted this position providing the benefit of his scientific expertise, leadership, knowledge of the research landscape. Genomics England’s vision is a world in which everyone has access to the benefits of genomics healthcare, Matt can help us deliver on that vision.”

Professor Brown commented: “I’m thrilled to be joining this iconic organisation working with its outstanding staff to deliver on the amazing promise genomics has to improve diagnosis management of a huge swathe of human diseases.”


The health social care division of The Access Group (“Access”), part of the local government, health social care software sectors, has announced the acquisition of Servelec.

The acquisition will enable Access to offer integrated solutions services across local government, health social care, combining Access’ suite of health social care solutions with Servelec’s ability to integrate technology across social care, healthcare, education youth services. 

With Integrated Care Systems in Englset to embed collaboration promote more joined-up care, the acquisition gives Access the opportunity to integrate systems data across the health social care sector. 

Steve Sawyer, managing director of The Access Group’s health social care division, will lead the enlarged business, supported by Servelec’s existing leadership team, including Steve Wightman, healthcare managing director, David McKinney, local government managing director. 


UK-based digital identity network Yoti has announced that it has contributed to the development of the Good Health Pass Interoperability Blueprint, which proposes a new set of specifications a format for digital health passes.

Applying data minimisation, it allows a verifier to request only the data required without compromising trust in an individual’s authenticity. This allows airlines governments to verify travellers’ COVID status, while simultaneously ensuring that factors such as privacy, security, user control, equity are protected. 

The Good Health Pass Collaborative brings together more than 125 global companies organisations from across the health, travel, technology sectors to develop principles standards for digital health passes for international travel. It is designed to protect public health by preventing the cross-border spread of COVID-19 with growing calls for digital health passes, both domestically internationally. 


Better quality research is needed before AI can be trusted to diagnose breast cancer in the full range of UK patients, according to the professional body for the IT industry. 

While AI may become an important method of breast screening in the near future, there is simply not good enough evidence yet, BCS, The Chartered institute for IT said.

There was a ‘significant risk of overdiagnosis’ should AI be adopted now in screening breast cancer, BCS added. 

The Institute said in its formal response to a consultation by the UK National Screening Committee’s (UK NSC) that it supports the NCS’ proposal that the use of AI for image analysis in breast cancer screening should not be endorsed in the UK at present.


CW+ North West London ICS/STP have been awarded over £1,100,000 from NHS Charities Together (NHSCT) to support shielding vulnerable people affected by COVID-19, by providing digital access to health, care community resources. CW+ is the charity of Chelsea Westminster Hospital NHS FT the lead charity for the North West London NHSCT application. 

CW+ will use funds from NHS Charities Together to support COVID-19 recovery activities, working with partners across the region to deliver the following digital inclusion innovation projects.

Lesley Watts, interim chief executive officer of North West London ICS/STP, chief executive of Chelsea Westminster Hospital NHS FT, said: “We are incredibly grateful to NHS Charities Together for their support funding, look forward to working in partnership with the national charity the successful bidders on this programme.  We need to support the health wellbeing of our most vulnerable patients affected by the COVID-19 pandemic. Our three new projects will help patients use digital health services tools as well as provide them with connections to local charitable services.”


A new programme has been launched to help national voluntary organisations from across multiple sectors particularly financial wellbeing, arts, nature physical activity to work together alongside local communities to increase the scale impact of social prescribing activities.    

The Accelerating Innovation in Social Prescribing programme is led by the National Academy for Social Prescribing, Royal Voluntary Service NHS EnglNHS Improvement in partnership with others. It will bring together a community of practice of national organisations to support their needs drive innovation to help maximise their contribution to the growing social prescribing community. 

Commenting, James Sanderson, chief executive of the National Academy for Social Prescribing, said: “National organisations have told us they have much to offer social prescribing. With their input we’ll be able to engage more people in activities that support their health wellbeing, particularly amongst communities affected by health inequalities COVID-19.    

“I’m delighted to launch this new programme of work with Royal Voluntary Service. Designed for by national organisations, this programme will empower them as active members of the social prescribing community. Together with local systems, we can unlock the power of social prescribing activities across the country help even more people impacted by health inequalities COVID-19.” 



Source link